The New Torrent
The 'pharmaceutical to power' group has kickstarted a makeover plan with focus on renewable and diversification into health.
The 'pharmaceutical to power' group has kickstarted a makeover plan with focus on renewable and diversification into health.
Moderna and Merck are experimenting a cancer vaccine, combining Merck’s cancer drug pembrolizumab (Keytruda) in the treatment process.
AstraZeneca’s vaccine was sold as Covishield in India. U.K.’s drugmaker says TTS could occur in “very rare” instances after its vaccine use and may lead to blood clotting and low platelet count
The quartet of vaccine-makers from the western world are ascertaining the need to tweak their vaccines for the Omicron, whereas WHO states it is too early to comment on its virulence.
Syngene International was started by Biocon in 1993 to provide research services for pharma companies. Three decades later, the entity wants to become a global science company in its own right.
A great pharma and medical supply chain, large population, intent among health professionals to innovate, and willingness among customers to try new solutions will ensure the sector's success.
Prices of vaccines may crash in the next few months. The vaccine makers will have to strike while the iron is hot.
Three firms have applied for emergency use authorisation in India as of now. AIIMS’ Amit Dinda, who is a part of the Global Coalition for Regulatory Science Research, explains the regulatory nuances.
As the world awaits a panacea for Covid-19, pharma companies have their feet firmly on the accelerator to get people a safe vaccine to stem the spiral of death and illness looming over humanity.